InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,635.34
(
0.91%
)
US TECH 100
19,850.80
(
0.88%
)
Dow Jones
40,109.40
(
0.89%
)
Brent Oil
85.02
(
-0.11%
)
Bitcoin
58,100.85
(
1.31%
)
Post# of 104535
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

drugmanrx

Send PM Follow Ignore
Followers 103
Posts 13610
Boards Moderated 1
Alias Born 01/23/2004

drugmanrx

Re: None

Wednesday, 05/01/2024 10:39:12 AM

Wednesday, May 01, 2024 10:39:12 AM

Post# of 104535
It doesn't look good for the home team.

Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product April 18, 2024

The Company entered into a license agreement with Lawson Health Research Institute (You remember these guys they gave QMC an exclusive in Nov 2022) for the worldwide exclusive rights to the intellectual property of novel blood biomarkers that characterize long COVID.



https://ca.finance.yahoo.com/news/revive-therapeutics-announces-fda-acceptance-110000050.html

No mention of QMC or quantum dots involved
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up